Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program.
Sakata J, Sasaki S, Handa K, Uchino T, Sasaki T, Higashita R, Tsuno N, Hiyoshi T, Morimoto S, Rinoie C, Saito N. Sakata J, et al. Among authors: hiyoshi t. Ostomy Wound Manage. 2012 Apr;58(4):36-49. Ostomy Wound Manage. 2012. PMID: 22466132 Free article.
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Gosho M, Mita T, Watada H. Fujitani Y, et al. Among authors: hiyoshi t. Diabetes Res Clin Pract. 2016 Nov;121:146-156. doi: 10.1016/j.diabres.2016.09.014. Epub 2016 Sep 22. Diabetes Res Clin Pract. 2016. PMID: 27710821 Clinical Trial.
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Murata T, Okazaki K, Yanagisawa K, Yamada K, Kuribayashi N, Totsuka Y, Hiyoshi T, Naka M, Sugimoto M, Aoki Y, Waki M, Furuya M, Kitaoka H, Oishi M, Shimizu I, Miyaoka H, Yamamoto T, Yamada K, Sakane N. Murata T, et al. Among authors: hiyoshi t. Diabetes Technol Ther. 2013 Sep;15(9):748-50. doi: 10.1089/dia.2012.0290. Epub 2013 Jun 12. Diabetes Technol Ther. 2013. PMID: 23758283
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Fuchigami A, Shigiyama F, Kitazawa T, Okada Y, Ichijo T, Higa M, Hiyoshi T, Inoue I, Iso K, Yoshii H, Hirose T, Kumashiro N. Fuchigami A, et al. Among authors: hiyoshi t. Cardiovasc Diabetol. 2020 Jan 7;19(1):1. doi: 10.1186/s12933-019-0977-z. Cardiovasc Diabetol. 2020. PMID: 31910850 Free PMC article. Clinical Trial.
116 results